Mochida Pharmaceutical Co., Ltd. (FRA:MFY)

Germany · Delayed Price · Currency is EUR

20.20

-0.20 (-0.98%)

Last updated: Feb 23, 2026, 8:22 AM CET

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Pharmaceutical	97.99B	96.46B	97.34B	104.45B	97.29B
Pharmaceutical Growth	1.59%	-0.91%	-6.80%	7.36%	0.84%
Healthcare Business	7.17B	6.43B	5.92B	5.73B	5.71B
Healthcare Business Growth	11.49%	8.61%	3.28%	0.40%	7.27%
Total	105.16B	102.89B	103.26B	110.18B	102.99B
Total Growth	2.21%	-0.36%	-6.28%	6.98%	1.17%

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Japan	105.16B	102.89B	103.26B	110.18B	103.00B
Japan Growth	2.21%	-0.36%	-6.28%	6.98%	1.17%
Total	105.16B	102.89B	103.26B	110.18B	103.00B
Total Growth	2.21%	-0.36%	-6.28%	6.98%	1.17%

Source: S&P Global Market Intelligence.